Home Nucleus Medical Devices Global Hereditary Cancer Testing Market to 2032

Global Hereditary Cancer Testing Market to 2032

Overview

The Global Hereditary Cancer Testing Market is expected to reach a 19.76 USD Billion by 2032 and is projected to grow at a CAGR of 14.73% from 2025 to 2032.

Revenue, 2024 (USD Billion)
7.04
Forecast, 2032 (USD Billion)
19.76
CAGR, 2024 - 2032
14.73%
Report Coverage
Global

Global Hereditary Cancer Testing Market 2018-2032 USD Billion

Global Hereditary Cancer Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 7.04 USD Billion
  • Projected Market Size (2032): 19.76 USD Billion
  • CAGR (2025-2032): 14.73%

Key Findings of Global Hereditary Cancer Testing Market

  • The Global Hereditary Cancer Testing Market was valued at 19.76 USD Billion in 2024.
  • The Global Hereditary Cancer Testing Market is likely to grow at a CAGR of 14.73% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 4.78 USD Billion
  • The fastest growing segment Hospitals in End Users Segment grew Fastest with a CAGR of 15.36% during the forecast period from 2024 to 2032.

Global Hereditary Cancer Testing Market Scope

Global Hereditary Cancer Testing Market Segmentation & Scope
Diagnosis
  • Lab Tests
  • Imagining
  • Biopsy
Test
  • Single Site Genetic Test
  • Multi Panel Test
Technology
  • Microarray
  • Sequencing
  • Polymerase Chain Reaction (PCR)
Distribution Channel
  • Retail Sales
  • Direct Tender
End Users
  • Others
  • Laboratories
  • Radiology Centres
  • Diagnostics Centers
  • Clinics
  • Hospitals
Disease
  • Multiple Endocrine Neoplasias (MEN) Syndrome
  • Von Hippel-Lindau Disease
  • Li-Fraumeni Syndrome
  • Familial Adenomatous Polyposis (FAP)
  • Hereditary Leukemia and Hematologic Malignancies Syndrome
  • Lynch Syndrome
  • Cowden Syndrome
  • Hereditary Breast & Ovarian Cancer Syndrome

Global Hereditary Cancer Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 7.04 USD Billion
Market Value in 2032 19.76 USD Billion
CAGR (2025-2032) 14.73%
Historic Data 2016-2023
Market Segments Covered Diagnosis,Test,Technology,Distribution Channel,End Users,Disease

Regional Insights:

  • Leading Market (2024-2032): Global, leading in terms of revenue 7.04 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 2,413.39 USD Million in 2024.

Segments and Scope

  • Global Hereditary Cancer Testing Market to 2032, By Diagnosis
    • Biopsy is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 3.02 USD Billion in the year 2024.
    • Biopsy is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 14.97 % in forecast period 2025-2032.
  • Global Hereditary Cancer Testing Market to 2032, By Test
    • Multi Panel Test is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 4.60 USD Billion in the year 2024.
    • Multi Panel Test is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 15.01 % in forecast period 2025-2032.
  • Global Hereditary Cancer Testing Market to 2032, By Technology
    • Polymerase Chain Reaction (PCR) is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 4.52 USD Billion in the year 2024.
    • Polymerase Chain Reaction (PCR) is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 15.07 % in forecast period 2025-2032.
  • Global Hereditary Cancer Testing Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 4.78 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 14.85 % in forecast period 2025-2032.
  • Global Hereditary Cancer Testing Market to 2032, By End Users
    • Hospitals is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 2.58 USD Billion in the year 2024.
    • Hospitals is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 15.36 % in forecast period 2025-2032.
  • Global Hereditary Cancer Testing Market to 2032, By Disease
    • Hereditary Breast & Ovarian Cancer Syndrome is the largest segment in Global Hereditary Cancer Testing Market to 2032 with a revenue of 3.99 USD Billion in the year 2024.
    • Hereditary Breast & Ovarian Cancer Syndrome is the Fastest growing segment in Global Hereditary Cancer Testing Market to 2032 with a Growth rate of 15.18 % in forecast period 2025-2032.

Global Hereditary Cancer Testing Market Company Share Analysis

 
Company Name Company Share Analysis
PerkinElmer Inc.
illumina, inc.
Abbott
Eurofins Scientific
LifeLabs Genetics
Global Hereditary Cancer Testing Market Company Share Analysis

Global Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Hereditary Cancer Testing Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Hereditary Cancer Testing Market Company Profiling

Global Hereditary Cancer Testing Market Company Profiling

Industry Related Reports

Global Cleanroom Technology Market
Global Cochlear Implant Market
Global Chronic Diseases Management Market
Global Hospital Furniture Market
Global Human Fibrin Glue Market
Global Healthcare 3D Printing Market
Global Hydrocephalus Market
Global Intraoperative Radiation Therapy Market
Global Surgical Power Tools Market
Global Inorganic Scintillators Market
Frequently Asked Questions
The Global Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Technology,Distribution Channel,End Users,Disease.
Global Hereditary Cancer Testing Market was valued at USD 7.04(Revenue in USD Billion) in 2020.
Global Hereditary Cancer Testing Market is projected to grow at a CAGR of 14.73% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Global Hereditary Cancer Testing Market, holding a largest market share of 4.78 USD Billion in 2024

Global Hereditary Cancer Testing Market Scope

Global Hereditary Cancer Testing Market Segmentation & Scope
Diagnosis
  • Lab Tests
  • Imagining
  • Biopsy
Test
  • Single Site Genetic Test
  • Multi Panel Test
Technology
  • Microarray
  • Sequencing
  • Polymerase Chain Reaction (PCR)
Distribution Channel
  • Retail Sales
  • Direct Tender
End Users
  • Others
  • Laboratories
  • Radiology Centres
  • Diagnostics Centers
  • Clinics
  • Hospitals
Disease
  • Multiple Endocrine Neoplasias (MEN) Syndrome
  • Von Hippel-Lindau Disease
  • Li-Fraumeni Syndrome
  • Familial Adenomatous Polyposis (FAP)
  • Hereditary Leukemia and Hematologic Malignancies Syndrome
  • Lynch Syndrome
  • Cowden Syndrome
  • Hereditary Breast & Ovarian Cancer Syndrome
Frequently Asked Questions
The Global Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Technology,Distribution Channel,End Users,Disease.
Global Hereditary Cancer Testing Market was valued at USD 7.04(Revenue in USD Billion) in 2020.
Global Hereditary Cancer Testing Market is projected to grow at a CAGR of 14.73% during the forecast period of 2024 to 2032.
The estimated market value of the Global Hereditary Cancer Testing Market for final year is USD 19.76 (USD Billion).

Global Hereditary Cancer Testing Market Company Profiling

Global Hereditary Cancer Testing Market Company Profiling
Frequently Asked Questions
The Global Hereditary Cancer Testing Market is segmented based on Segmentation Diagnosis,Test,Technology,Distribution Channel,End Users,Disease.
Global Hereditary Cancer Testing Market was valued at USD 7.04(Revenue in USD Billion) in 2020.
Global Hereditary Cancer Testing Market is projected to grow at a CAGR of 14.73% during the forecast period of 2024 to 2032.
The estimated market value of the Global Hereditary Cancer Testing Market for final year is USD 19.76 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES